Developing a novel diagnosis test for monitoring treatment success of drug resistant TB in low income areas

Texas Biomedical Research Institute

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)

Jordi Torrelles

Funded by

TxBiomed Forum

Research Start Date

10/01/2018

Status

Inactive

We aim to develop and test the performance of a 2nd generation TB Color Plate test with the ultimate goal of developing and implementing a faster (14 vs. 56-84 days), field-based, easy-to-use, and inexpensive drug susceptibility testing (DST) for drug-resistant TB in high TB index rate regions. This will allow faster detection, cost reductions, and thus, significantly aid in preventing transmission of drug-resistant TB in humans.

Collaborative Project

Basic Research

Medical Devices

Infectious Disease

Bioscience Research Panel

Developing a novel diagnosis test for monitoring treatment success of drug resistant TB in low income areas